SMC December Update

December 11, 2008 on 3:19 pm | In Prescribing Extra - Drugs | Print Print | No Comments

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Flecainide modified release 200mg capsules (Tambocor XL®) have been accepted for use in treating a variety of cardiac arrhythmias including AV nodal reciprocating tachycardia, Wolff-Parkinson-White Syndrome and atrial fibrillation in patients with disabling symptoms. It is also noted that the once-daily product has a lower acquisition cost than a twice-daily product at equivalent doses.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Copyright ©2008 Prescribing Advice for GPs

No Comments yet »

RSS feed for comments on this post. TrackBack URI

Leave a comment

XHTML: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS Feed for New Entries.
Akismet has protected Prescribing Advice for GPs from 3,465 spam comments.